<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="26537">Retinoids</z:chebi> are known to induce the differentiation and cell cycle arrest of human myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Differential display was used to identify putative early regulatory genes that are differentially expressed in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 human promyelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells treated with <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>One of the cDNAs cloned encodes sequences identifying Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> receptor 1 (BLR1), a recently described chemokine receptor </plain></SENT>
<SENT sid="3" pm="."><plain>Northern blot analysis demonstrates that blr1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression increases within 9 h of <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> treatment, well before functional differentiation or G(1)/G(0) <z:mpath ids='MPATH_73'>growth arrest</z:mpath> at 48 h or <z:hpo ids='HP_0003674'>onset</z:hpo> of morphological changes, suggesting a possible regulatory function </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of blr1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> is transient, peaking at 72 h when cells are differentiated </plain></SENT>
<SENT sid="5" pm="."><plain>blr1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> also is induced by other differentiation-inducing agents, 1alpha,25-dihydroxyvitamin D(3) and DMSO </plain></SENT>
<SENT sid="6" pm="."><plain>Induction of blr1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> by <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> is not blocked by the <z:chebi fb="0" ids="48001">protein synthesis inhibitor</z:chebi> <z:chebi fb="0" ids="27641">cycloheximide</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells stably transfected with blr1 cDNA, ectopic expression of blr1 causes an increase in ERK2 MAPK activation and promotes <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>-induced G(1)/G(0) <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and cell differentiation </plain></SENT>
<SENT sid="8" pm="."><plain>The early expression of blr1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> during differentiation, its ability to increase ERK2 activation, and its enhancement of <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>-induced differentiation suggest that blr1 expression may be involved in <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>-induced <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 differentiation </plain></SENT>
</text></document>